Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-21

Clinical Trial Update: Assessment of Prevident Sodium Fluoride 1.1% Toothpaste Using an Intra-oral Remineralization-demineralization Model [Phase 2]

View source ↗

Summary

Phase 2 trial of Prevident Sodium Fluoride 1.1% toothpaste was withdrawn (status change) after evaluation in an intra-oral remineralization-demineralization mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prevident Sodium Fluoride 1.1% toothpaste (sodium fluoride toothpaste)

Snippet

Sponsor: Colgate Palmolive | Conditions: Dental Caries | Phase 2 | Status: WITHDRAWN